INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 48m ago
HOUSE PTR8m ago
SEC 13F8m ago
ROBINHOOD CHAIN8m ago
BE
Corporate insider

Benevich Eric

Chief Commercial OfficerCIK 0001643653

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 1
Max Insider Score21
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
6
BE
Benevich EricChief Commercial Officer
NBIXNEUROCRINE BIOSCIENCES INC
Option exercise · 10b5-1 plan
M$138K
3,194 sh
Sep 9, 2026Sep 10, 2026
traded Sep 9, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    NEUROCRINE BIOSCIENCES INCChief Commercial Officer · Sep 10, 2026
21
BE
Benevich EricChief Commercial Officer
NBIXNEUROCRINE BIOSCIENCES INC
Open-market sale · 10b5-1 plan
SELL
$333K
2,154 sh
Sep 9, 2026
Sep 10, 2026
traded Sep 9, 2026
+1d
SEC FORM 4

Evidence

0
BE
Benevich EricChief Commercial Officer
NBIXNEUROCRINE BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
3,194 sh
Sep 9, 2026Sep 10, 2026
traded Sep 9, 2026
+1dSEC FORM 4

Evidence